Platelet Aggregation Devices Market, Share, Growth, Opportunity and Forecast By 2021-2026


According to the latest report by IMARC Group, titled “Platelet Aggregation Devices Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026; the global platelet aggregation devices market exhibited moderate growth during 2015-2020.Platelet aggregation devices consist of adenosine-diphosphate (ADP), thrombin, and ristocetin-induced platelet aggregation (RIPA). These devices are utilized to diagnose patients with inherited and acquired platelet function disorders, including excessive bleeding, arterial thrombotic, stroke, myocardial infarction, etc. Platelet aggregation devices aid in transfusing medicines, pre-surgery tests, and clinical settings to monitor the response of antiplatelet therapies and assess perioperative bleeding risk. Presently, due to the launch of new potential biomarkers and technologies, platelet aggregation devices are finding extensive applications in personalizing antiplatelet drugs and monitoring the efficacy of several pro-hemostatic therapies around the world.

Request for a PDF sample of this report:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

The increasing instances of platelet aggregation among patients diagnosed with the coronavirus disease (COVID-19) are driving the platelet aggregation devices market. Furthermore, the elevating prevalence of colon cancer, cardiovascular diseases, Kawasaki condition, acute coronary syndrome (ACS), acute ischemic stroke, etc., is also propelling the growth of the market. Besides this, a significant rise in the aging population suffering from chronic diseases is another growth-inducing factor. In addition to this, several key manufacturers are launching novel products to expand their product portfolio, which is further augmenting the market growth. Additionally, the escalating need for POC diagnostic devices to fulfill the healthcare demand of the population will continue to bolster the platelet aggregation devices market over the forecasted period. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026.

Competitive Landscape: 

  • Aggredyne Inc
  • Chrono-Log Corporation
  • F. Hoffmann-La Roche AG
  • Grifols S.A
  • Hart Biologicals Ltd
  • Helena Laboratories Corporation
  • LAbor BioMedical Technologies GmbH
  • Matis Medical Inc
  • Sentinel Ch. S.P.A
  • Siemens AG, Sienco Inc
  • Sysmex Corporation
  • WerfenLife SA.

Key Market Segmentation:

Breakup by Product:

  • Systems
  • Reagents
  • Consumables and Accessories 

Breakup by Type:

  • Four Channel
  • Dual Channel
  • Eight Channel 

Breakup by Application:

  • Clinical Applications
  • Research Applications
  • Cardiovascular Applications
  • Orthopedic Applications
  • Others

Breakup by End User:

We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                             

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

About Us                                                                      

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming


Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800